Michael Ploug

10.7k total citations · 1 hit paper
157 papers, 8.8k citations indexed

About

Michael Ploug is a scholar working on Cancer Research, Hematology and Molecular Biology. According to data from OpenAlex, Michael Ploug has authored 157 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Cancer Research, 46 papers in Hematology and 44 papers in Molecular Biology. Recurrent topics in Michael Ploug's work include Protease and Inhibitor Mechanisms (77 papers), Blood Coagulation and Thrombosis Mechanisms (45 papers) and Peptidase Inhibition and Analysis (37 papers). Michael Ploug is often cited by papers focused on Protease and Inhibitor Mechanisms (77 papers), Blood Coagulation and Thrombosis Mechanisms (45 papers) and Peptidase Inhibition and Analysis (37 papers). Michael Ploug collaborates with scholars based in Denmark, United States and Japan. Michael Ploug's co-authors include Keld Danø, Niels Behrendt, Henrik Gårdsvoll, Vincent Ellis, Ebbe Rønne, Gunilla Høyer‐Hansen, Francesco Blasi, Thomas J. D. Jørgensen, A. L. Jensen and Leif R. Lund and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Michael Ploug

155 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

1991 518 citations Michael Ploug, Niels Behrendt et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Michael Ploug

Since Specialization

Citations

This map shows the geographic impact of Michael Ploug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ploug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ploug more than expected).

Fields of papers citing papers by Michael Ploug

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ploug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ploug. The network helps show where Michael Ploug may publish in the future.

Co-authorship network of co-authors of Michael Ploug

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ploug. A scholar is included among the top collaborators of Michael Ploug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ploug. Michael Ploug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer models 2025 ·Science Advances ·(unknown), (unknown), Ananya Dutta, Henrik Gårdsvoll, (unknown), (unknown), Henrik J. Jürgensen, Michael Ploug, Matthew J. Flick, Niels Behrendt, Lars H. Engelholm	1
2	Quantification of lipoprotein lipase in mouse plasma with a sandwich enzyme-linked immunosorbent assay 2024 ·Journal of Lipid Research ·Takao Kimura, Kazuya Miyashita, Isamu Fukamachi, (unknown), (unknown), (unknown), Katsuhiko Tsunekawa, (unknown), Michael Ploug, (unknown), Wenxin Song, Stephen G. Young, Anne P. Beigneux, Katsuyuki Nakajima, Masami Murakami	2
3	The lipoprotein lipase that is shuttled into capillaries by GPIHBP1 enters the glycocalyx where it mediates lipoprotein processing 2023 ·Proceedings of the National Academy of Sciences ·Wenxin Song, Anne P. Beigneux, Thomas A. Weston, Kai Chen, (unknown), (unknown), Paul Guagliardo, (unknown), (unknown), Yiping Tu, (unknown), Gabriel Birrane, Kazuya Miyashita, Katsuyuki Nakajima, Masami Murakami, Peter Tontonoz, Haibo Jiang, Michael Ploug, Loren G. Fong, Stephen G. Young	6
4	Targeted imaging of uPAR expression in vivo with cyclic AE105 variants 2023 ·Scientific Reports ·(unknown), Estella A. Newcombe, (unknown), Jesper Tranekjær Jørgensen, (unknown), (unknown), (unknown), Andreas Kjær, Birthe B. Kragelund, Thomas J. D. Jørgensen, Michael Ploug	3
5	Intracapillary LPL levels in brown adipose tissue, visualized with an antibody-based approach, are regulated by ANGPTL4 at thermoneutral temperatures 2023 ·Proceedings of the National Academy of Sciences ·Wenxin Song, (unknown), Patrick J. Heizer, Yiping Tu, Thomas A. Weston, (unknown), (unknown), (unknown), (unknown), (unknown), Michael Ploug, Anne P. Beigneux, Stephen G. Young, Loren G. Fong	10
6	Expression and one-step purification of active LPL contemplated by biophysical considerations 2021 ·Journal of Lipid Research ·Anne-Marie Lund Winther, Kristian Kølby Kristensen, (unknown), Michael Ploug	7
7	The Importance of Lipoprotein Lipase Regulation in Atherosclerosis 2021 ·Biomedicines ·(unknown), Kristian Kølby Kristensen, Michael Ploug, Anne-Marie Lund Winther	53
8	The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding 2021 ·Proceedings of the National Academy of Sciences ·(unknown), Kristian Kølby Kristensen, (unknown), Anne-Marie Lund Winther, Stephen G. Young, Thomas J. D. Jørgensen, Michael Ploug	35
9	ANGPTL4 sensitizes lipoprotein lipase to PCSK3 cleavage by catalyzing its unfolding 2021 ·Journal of Lipid Research ·Anne-Marie Lund Winther, (unknown), Stephen G. Young, Michael Ploug	13
10	Chylomicronemia from GPIHBP1 autoantibodies 2020 ·Journal of Lipid Research ·Kazuya Miyashita, Jens Lutz, Lisa C. Hudgins, (unknown), Ambika P. Ashraf, Wenxin Song, Masami Murakami, Katsuyuki Nakajima, Michael Ploug, Loren G. Fong, Stephen G. Young, Anne P. Beigneux	26
11	Unfolding of monomeric lipoprotein lipase by ANGPTL4: Insight into the regulation of plasma triglyceride metabolism 2020 ·Proceedings of the National Academy of Sciences ·Kristian Kølby Kristensen, (unknown), Haydyn D. T. Mertens, Gabriel Birrane, M. Muthuraman, Gunilla Olivecrona, Thomas J. D. Jørgensen, Stephen G. Young, Michael Ploug	54
12	Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond? 2019 ·Journal of Biological Chemistry ·(unknown), Haydyn D. T. Mertens, (unknown), Thomas J. D. Jørgensen, Michael Ploug	12
13	Evolution and Medical Significance of LU Domain−Containing Proteins 2019 ·International Journal of Molecular Sciences ·(unknown), (unknown), Kristian Kølby Kristensen, (unknown), Anne-Marie Lund Winther, Stephen G. Young, Michael Ploug	29
14	Peptide Disc Mediated Control of Membrane Protein Orientation in Supported Lipid Bilayers for Surface-Sensitive Investigations 2019 ·Analytical Chemistry ·Alessandra Luchini, (unknown), Nicolai Tidemand Johansen, Mario Campana, Javier Sotres, Michael Ploug, Marité Cárdenas, Lise Arleth	16
15	GPIHBP1 autoantibody syndrome during interferon β1a treatment 2018 ·Journal of clinical lipidology ·Jun Eguchi, Kazuya Miyashita, Isamu Fukamachi, Katsuyuki Nakajima, Masami Murakami, Yuko Kawahara, Toru Yamashita, Yasuyuki Ohta, Koji Abe, Atsuko Nakatsuka, (unknown), Satoru Takase, Hiroaki Okazaki, Robert A. Hegele, Michael Ploug, Xuchen Hu, Jun Wada, Stephen G. Young, Anne P. Beigneux	15
16	Structure of the lipoprotein lipase–GPIHBP1 complex that mediates plasma triglyceride hydrolysis 2018 ·Proceedings of the National Academy of Sciences ·Gabriel Birrane, Anne P. Beigneux, Brian Dwyer, (unknown), Kristian Kølby Kristensen, Omar L. Francone, Loren G. Fong, Haydyn D. T. Mertens, Clark Q. Pan, Michael Ploug, Stephen G. Young, M. Muthuraman	63
17	Expression and crystallographic studies of the D1D2 domains of C4.4A, a homologous protein to the urokinase receptor 2017 ·Acta Crystallographica Section F Structural Biology Communications ·(unknown), Lin Lin, Cai Yuan, Henrik Gårdsvoll, Mette C. Kriegbaum, Michael Ploug, Mingdong Huang	1
18	GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia 2017 ·Journal of clinical lipidology ·Xuchen Hu, Geesje M. Dallinga‐Thie, G. Kees Hovingh, Sandy Y. Chang, Norma P. Sandoval, (unknown), Isamu Fukamachi, Kazuya Miyashita, Katsuyuki Nakajima, Masami Murakami, Loren G. Fong, Michael Ploug, Stephen G. Young, Anne P. Beigneux	25
19	Improved PET Imaging of uPAR Expression Using new ⁶⁴Cu-labeled Cross-Bridged Peptide Ligands: Comparative in vitro and in vivo Studies 2013 ·Theranostics ·Morten Persson, Masood Hosseini, Jacob Madsen, Thomas J. D. Jørgensen, Knud J. Jensen, Andreas Kjær, Michael Ploug	44
20	Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation 2010 ·Blood ·B. Connolly, Eun Young Choi, Henrik Gårdsvoll, Alexandra L. Bey, Brooke M. Currie, Triantafyllos Chavakis, Shihui Liu, Alfredo A. Molinolo, Michael Ploug, Stephen H. Leppla, Thomas Bugge	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact